Cranbrook Wealth Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Cranbrook Wealth Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,000	Closed	-$7K	–	244
2017 Q1	$7K	Hold	2,000	–	–	﹤0.01%	180
2016 Q4	$10K	Buy	2,000 +500	+33%	+$14.8K	﹤0.01%	178
2016 Q3	$69K	Sell	1,500 -250	-14%	-$14.1K	0.03%	90
2016 Q2	$89K	Hold	1,750	–	–	0.05%	81
2016 Q1	$74K	Buy	1,750 +750	+75%	+$38.2K	0.04%	88
2015 Q4	$79K	Hold	1,000	–	–	0.04%	82
2015 Q3	$41K	Hold	1,000	–	–	0.02%	107
2015 Q2	$52K	Hold	1,000	–	–	0.03%	105
2015 Q1	$47K	Hold	1,000	–	–	0.03%	104
2014 Q4	$45K	Hold	1,000	–	–	0.03%	108
2014 Q3	$39K	Hold	1,000	–	–	0.03%	91
2014 Q2	$42K	Hold	1,000	–	–	0.03%	88
2014 Q1	$0	Buy	+1,000	New	+$33.7K	﹤0.01%	237

Other funds holding ISEE

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cranbrook Wealth Management's ISEE Position: Q2 2017 in Review

Cranbrook Wealth Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2017, closing a stake of 2,000 shares — an estimated $7K sold.

Cranbrook Wealth Management first reported a position in ISEE in Q1 2014 and held it in 13 quarters. The position peaked at $89K in Q2 2016. 77 funds tracked by Wall St. Rank hold ISEE as of Q2 2017.

Cranbrook Wealth Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
Cranbrook Wealth Management sold 2,000 IVERIC bio, Inc. Common Stock shares in Q2 2017, an estimated $7K.
Cranbrook Wealth Management first reported a position in IVERIC bio, Inc. Common Stock in Q1 2014 and held it in 13 quarters.
Cranbrook Wealth Management's IVERIC bio, Inc. Common Stock position peaked at $89K in Q2 2016.
77 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2017.

Based on Cranbrook Wealth Management's 13F filing for Q2 2017, filed 10 Aug 2017.